Divi's Laboratories informs about schedule of analyst meeting

21 Aug 2019

Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Divi's Laboratories has informed about the schedule of meeting(s) with the Analyst(s)/ investor(s): Axis Capital & others to be held on 22 August, 2019. 

The above information is a part of company’s filings submitted to BSE.

Related Divis Laboratories Ltd. Links:

Divis Lab Share Price

3057.30 -35.60 (-1.15%) Sep 29, 16:47
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 505.60
Dr. Reddys Lab 5083.50
Lupin 995.00
Piramal Enterprises 1253.15
Cadila Healthcare 386.75
View more..
Sensex vs Divis Lab
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719